ArticleTherapeutic advances in musculoskeletal disease2026
Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study.
Chung-Mao Kao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.